SLU-PP-332: Exercise Mimetic Peptide Research

What is SLU-PP-332?

What if a single research compound could trigger the metabolic adaptations of strenuous physical training without a single step on the treadmill? SLU-PP-332 is generating massive excitement across metabolic and exercise physiology laboratories for doing precisely that.

SLU-PP-332 is a novel synthetic compound designed as a potent pan-agonist of Estrogen-Related Receptors (ERRs). Developed by visionary researchers at Saint Louis University led by Dr. Thomas Burris, this compound directly targets nuclear receptors controlling cellular respiration and muscle energy expenditure.

By activating ERR signaling cascades, SLU-PP-332 tricks muscle tissue into behaving as though it has undergone grueling endurance workouts. Scientists classify it among the most effective "exercise mimetics" ever discovered.

Unlike standard energy supplements or central nervous system stimulants, SLU-PP-332 reshapes cellular gene expression. It turns on the body's natural endurance program, driving rapid mitochondrial biogenesis and fat oxidation.

Researchers exploring muscle wasting, metabolic syndrome, and elite endurance performance are rapidly adopting SLU-PP-332 to unlock new frontiers in metabolic science.

How SLU-PP-332 Works (ERRα/β/γ agonist, exercise pathway)

To understand how SLU-PP-332 exerts its profound effects, you must look inside the nucleus at Estrogen-Related Receptors (ERRs). Despite their historical name, ERRs do not bind estrogen. Instead, they are orphan nuclear receptors that serve as master switches for mitochondrial energy production.

The ERR family comprises three distinct receptor isoforms: ERRα, ERRβ, and ERRγ. ERRα and ERRγ are expressed at exceptionally high levels in energy-demanding tissues such as skeletal muscle, cardiac muscle, and brown adipose tissue.

SLU-PP-332 functions as a synthetic pan-agonist, binding directly to ERRα, ERRβ, and ERRγ with high potency. Upon binding, it activates the PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) coactivator network—the exact transcriptional cascade triggered by physical exercise.

This targeted receptor activation initiates a sweeping genetic transformation within skeletal muscle cells:

• Mitochondrial Biogenesis: SLU-PP-332 dramatically multiplies mitochondrial density, volume, and total respiratory capacity.
• Muscle Fiber Reprogramming: It drives muscle fiber switching, transforming fast-twitch glycolytic fibers into fatigue-resistant, oxidative Type I slow-twitch fibers.
• Fatty Acid Oxidation Upregulation: It boosts key metabolic enzymes like CPT1b and MCAD, forcing cells to burn stored lipids as their primary energy fuel.
• Optimized ATP Output: By enhancing electron transport chain efficiency, cells generate far more ATP per unit of oxygen consumed.

Through this exact molecular pathway, SLU-PP-332 replicates the metabolic blueprint of endurance exercise directly within cellular DNA.

Muscle Endurance and Fat Loss Research

Preclinical research on SLU-PP-332 has produced remarkable outcomes across metabolic, endurance, and body composition parameters. In landmark animal studies, researchers thoroughly evaluated the compound's impact on exercise capacity and tissue physiology.

When administered to rodent models, SLU-PP-332 triggered dramatic spikes in physical stamina. Treated subjects demonstrated up to a 70% increase in treadmill endurance and ran 45% farther than control models—without any prior exercise training.

Equally remarkable is SLU-PP-332's capacity to drive targeted body fat reduction while fully protecting lean muscle tissue. Subjects receiving the compound lost significant fat mass without experiencing muscle atrophy.

Importantly, this rapid fat loss occurred without altering food intake or forcing physical movement. The compound elevated baseline metabolic rate, increased systemic oxygen consumption (VO2), and shifted cellular substrate preference from carbohydrates to body fat stores.

Furthermore, research demonstrates that SLU-PP-332 offers robust protection against metabolic decline. It prevents high-fat diet-induced obesity, improves systemic insulin sensitivity, and reduces hepatic steatosis (fatty liver).

These findings highlight SLU-PP-332's immense potential for treating sarcopenia, age-related muscle loss, and metabolic disorders in clinical models.

SLU-PP-332 vs MOTS-c (both exercise mimetics, different targets)

In the landscape of exercise mimetics, SLU-PP-332 and MOTS-c represent the two most prominent scientific breakthroughs. While both compounds simulate the health benefits of exercise, they operate via entirely different physiological pathways.

MOTS-c is a mitochondrial-derived peptide composed of 16 amino acids. It functions primarily by activating AMPK (AMP-activated protein kinase), serving as an enzymatic stress sensor that enhances cellular glucose uptake and systemic insulin sensitivity.

SLU-PP-332, by contrast, is a synthetic small-molecule agonist targeting nuclear ERRs. Rather than acting strictly as an enzymatic stress signal, SLU-PP-332 directly reprograms nuclear gene transcription to build mitochondrial infrastructure and convert muscle fiber types.

The table below summarizes the key mechanistic differences between these leading research compounds:

Feature	SLU-PP-332	MOTS-c	5-Amino-1MQ
Compound Type	Synthetic Small Molecule	Mitochondrial Peptide (16 aa)	Synthetic Small Molecule
Primary Target	ERRα / ERRβ / ERRγ Agonist	AMPK Activator / MDP	NNMT Enzyme Inhibitor
Key Mechanism	Nuclear gene transcription & PGC-1α pathway	Mitochondrial-to-nucleus retrograde signaling	NAD+ preservation & SAM methylation regulation
Primary Effect	Muscle endurance & fiber type switching	Insulin sensitivity & metabolic flexibility	Fat cell shrinkage & intracellular NAD+ boost
Research Focus	Exercise mimetic & muscle performance	Longevity & systemic metabolic health	Adiposity reduction & cellular energy

While MOTS-c is ideal for investigating systemic metabolic health and glucose control, SLU-PP-332 is unmatched for studies targeting skeletal muscle oxidation, physical endurance, and structural muscle adaptation.

The Bottom Line

SLU-PP-332 represents a major leap forward in exercise mimetic research. By directly targeting Estrogen-Related Receptors, it proves that physical stamina and fat burning can be turned on at the nuclear level without physical strain.

Whether your laboratory focuses on muscle preservation, endurance signaling, or metabolic disease intervention, SLU-PP-332 offers an extraordinary research tool. High-purity SLU-PP-332 is available to order for certified scientific investigation.